Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04506164 · ClinicalTrials.gov registry record · NA

Effectiveness and Implementation of eScreening in Post 9/11 Transition Programs

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
72
Enrollment target

NCT04506164: Completed NA study, sponsored by VA Office of Research and Development.

NCT04506164 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04506164, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target

Study Summary

Electronic screening is effective for timely detection of, and intervention for, suicidal ideation and other mental health symptoms. The VA eScreening program is a patient self-report electronic screening system that has shown promise for the efficient and effective collection of mental and physical health information among Veterans. However, additional effectiveness and implementation research is warranted to evaluate the impact of eScreening within VHA. This study addresses questions of the impact of eScreening compared to screening as usual, while evaluating a multi-component implementation strategy (MCIS) for optimal enterprise rollout of eScreening in VA Transition Care Management clinics.

Interventions

  • OTHER eScreening
  • OTHER Screening As Usual

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2021-06-18
Est. Completion 2024-12-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT04506164

The ClinicalTrials.gov registry entry for NCT04506164 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which eScreening is the first listed.

NCT04506164 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04506164 about?

NCT04506164 is a clinical study titled "Effectiveness and Implementation of eScreening in Post 9/11 Transition Programs". Electronic screening is effective for timely detection of, and intervention for, suicidal ideation and other mental health symptoms. The VA eScreening program is a patient self-report electronic screening system that has shown promise for the efficient and effective collection of mental and physical...

What is the current status of trial NCT04506164?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2021-06-18. Estimated completion is 2024-12-31.

What interventions are being tested in trial NCT04506164?

The interventions under investigation include: eScreening (OTHER), Screening As Usual (OTHER).

Who is sponsoring clinical trial NCT04506164?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.